- cvss
- 7.8
- version 3.1, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.5%
- EPSS 0.5% chance of exploitation in 30 days, percentile 40%
- public exploits
- 0
- none known
Summary
A DLL hijacking vulnerability in the B. Braun OnlineSuite Version AP 3.0 and earlier allows local attackers to execute code on the system as a high privileged user.
Is CVE-2020-25174 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerVendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSMA-20-296-01 updated cvss 8.4
B. Braun OnlineSuite
-
B. Braun Medical AP <= 3.0affected: vendor fix bbraun.com
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
Exploit prediction
0.47% chance of exploitation in the next 30 days, higher than 40% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 3.1 | 7.8 | CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H |
| NVD | 2.0 | 6.9 | AV:L/AC:M/Au:N/C:C/I:C/A:C |
Affected products
- B. Braun Melsungen AG OnlineSuite
Classification
- Weakness
-
- CWE-427 Uncontrolled Search Path Element
References
-
us-cert.cisa.gov
/ics/advisories/icsma-20-296-01
third-party-advisory, us-government-resource
Sources
- CVE List CVE-2020-25174
- NVD CVE-2020-25174
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.